Paul Clevelan
Chairman
Healthcare
Bioagri Laboratories
United States of America
Biography
Effective December 9, 2015, Mr. Cleveland will serve as Chief Executive Officer and member of the board of directors of Avalanche Biotechnologies, Inc. Previously, he was President and Chief Executive Officer of Celladon Corporation, and prior to that, was Celladon’s President and Chief Financial Officer. Mr. Cleveland also currently serves as a member of the board of directors and as Chairman of the Audit Committee of Sangamo Biosciences, Inc. Prior to Celladon, he served as Executive Vice President, Corporate Strategy and Chief Financial Officer at Aragon Pharmaceuticals before its acquisition by Johnson & Johnson. Prior to Aragon, he was General Partner and Chief Operating Office at Mohr Davidow Ventures and Executive Vice President, Corporate Development and Chief Financial Officer for Affymax. He previously was an investment banker at J.P. Morgan Chase and Co. and a predecessor firm, Hambrecht & Quist, and a corporate lawyer at Cooley LLP, Sidley Austin LLP, and Davis Polk & Wardwell LLP. Mr. Cleveland holds a bachelor’s degree from Washington University in St. Louis and a J.D. from Northwestern University School of Law.
Research Interest
Effective December 9, 2015, Mr. Cleveland will serve as Chief Executive Officer and member of the board of directors of Avalanche Biotechnologies, Inc. Previously, he was President and Chief Executive Officer of Celladon Corporation, and prior to that, was Celladon’s President and Chief Financial Officer. Mr. Cleveland also currently serves as a member of the board of directors and as Chairman of the Audit Committee of Sangamo Biosciences, Inc. Prior to Celladon, he served as Executive Vice President, Corporate Strategy and Chief Financial Officer at Aragon Pharmaceuticals before its acquisition by Johnson & Johnson. Prior to Aragon, he was General Partner and Chief Operating Office at Mohr Davidow Ventures and Executive Vice President, Corporate Development and Chief Financial Officer for Affymax. He previously was an investment banker at J.P. Morgan Chase and Co. and a predecessor firm, Hambrecht & Quist, and a corporate lawyer at Cooley LLP, Sidley Austin LLP, and Davis Polk & Wardwell LLP. Mr. Cleveland holds a bachelor’s degree from Washington University in St. Louis and a J.D. from Northwestern University School of Law.